|
THE OFFICE OF RESEARCH
NEW INVESTIGATORS: A QUICK GUIDE TO STARTING YOUR RESEARCH AT
UCSF
Table
of Contents
Obtaining Regulatory Committee Approvals
- Other Topics:
| Making Sense of the Regulations | What
is Research Online? | Working with
Biologicals | Working with Chemicals | Working
with Radioactive Materials | Working
with Radioactive Materials in Humans | Working
with Controlled Substances at UCSF | Working
with Animals |
Serving on the Committees | Working
with UCSF's Affiliates |
OBTAINING REGULATORY COMMITTEE APPROVALS
Involving human subjects in your research
• Does my study require human subject research review and approval?
• Who do I contact?
• What types of approvals do I need to work with human subjects?
• What training is required?
• Is auditing or monitoring required?
• What are my additional responsibilities
for clinical research?
• Top Tips to speed up approval and prevent problems
• Relevant polices, procedures, and ethical statements
Does my study require human subject research review and approval?
Any research that involves either the participation
of human subjects or the use of human biological specimens, medical charts,
or databases
with information about humans is considered to be human
subject research and requires review.
The Committee
on Human Research (CHR) reviews human subject research
to ensure the ethical and equitable treatment of those
subjects under federal and state laws.
The CHR is part of the Human Subjects
Protection Program (HSPP) in the Office of Research.
The CHR is UCSF’s
federally mandated Institutional Review Board (IRB).
Top
of page
Who do I contact?
The main number for the CHR is (415) 476-1814. The CHR front desk will
answer routine questions. Complex questions are referred to an “analyst
of the day”. See also the
CHR
Contact Information and the main
CHR web site.
Top
of page
What types of approvals do I need to work
with human subjects?
You need Committee
on Human Research (CHR) approval. All research on
human subjects (including the use of biospecimens,
medical charts, and data) must be submitted to the CHR for review and
approval prior to any
contact with human subjects or any use of their specimens,
records, or data. Depending on the nature of your research, you may
need additional
approvals.
There are three types of CHR review, with separate application formats.
The type of application needed depends on the degree of risk to
subjects:
| • |
Full
Committee: more than minimal risks to subjects, reviewed by one of three full
CHR committees |
|
| • |
Expedited: no more than minimal
risks, reviewed by a subcommittee of the CHR |
|
•
 |
Exempt
Certification: technically
exempt from the need for CHR review, but requires
submission and review of a form for certification
of exempt status |
Approval turnaround time: Full Committee
and Expedited approvals usually take from 2 weeks to
8 weeks depending on the type of human research,
the level of risk, and the complexity of ethical or
technical questions that arise during review. Exempt
certifications usually can be issued
within a week. You should allow extra time during holiday
and vacation periods.
Expiration date: Most human research
projects are given approval for one-year but some may
receive a shorter term of approval based on the CHR’s
perception of the need for more frequent review. The
expiration date is absolute, and by federal law, the
CHR cannot grant an extension. You must obtain approval
of your renewal before the expiration date.
(Renewal
Application)
If your approval expires, you
must stop your research until you receive a new CHR
approval. However, if it would jeopardize subjects
to suspend ongoing treatment or follow-up tests,
you must continue activities needed to ensure
the safety of the subjects
Modifications: You cannot modify CHR
approved procedures without prior review and additional approval from
the CHR. You need CHR approval for
additions, deletions, or substitutions to your research
protocol, informed consent documents, recruitment procedures, questionnaires,
or other previously
approved documents. Failing to follow your approved
protocol or using documents altered without approval is a serious violation
of federal
regulations. (
CHR
Modifications)
Additional approvals:
Authorizations or approvals may
also be required from the
Technical
Committees: biologicals (
BUA),
radioisotopes (
RUA,
RUA for Humans) and/or controlled substances (
CSP).
If human stem cells, either embryonic
or adult, will be used in the study,
then the
Human
Stem Cell Research Supplement must be submitted with the
CHR application. Human stem cell research is carefully
regulated and may require additional approvals.
See the
Human
Stem Cell web site for
UCSF guidance and policies.
The Comprehensive
Cancer Center, Clinical Research Centers:
GCRC and
PCRC, and the
Veterans
Affairs Medical Center also have review requirements.
Top of page
What training is required?
Investigators who will work with human subjects must
complete the UCSF Research Online
Human
Subjects Training before the CHR
gives final approval. The CHR tracks this online
training to document compliance with Federal training
requirements. UCSF also requires completion
of an online
HIPAA
research training module. For other clinical training
and links to useful clinical services see What Research Services
are Available at UCSF? in this Quick Guide.
Top of page
Is auditing or monitoring required?
All human subjects studies at UCSF are subject to auditing
or monitoring.
The UCSF Human Subjects Protection Program includes
a Quality
Improvement Unit (QIU) that provides quality assurance, quality
improvement,
and
educational activities to:
| • |
monitor the conduct of clinical
research to ensure the rights and welfare of human
research subjects |
|
•
|
optimize compliance with federal,
state, and institutional regulations and policies. |
Audit types include both for-cause audits and random
quality improvement assessments (not-for-cause audits). Other groups
internal
to UCSF that may audit your research are:
External audits also may be done as
part of federal, university, or sponsor programs.
If you receive adverse findings from an outside auditor,
you should notify the CHR immediately.
If needed, the CHR and UCSF Legal Counsel can
assist in the preparation of a response. Failing to
respond properly may jeopardize your and UCSF’s
human research programs. External groups that may audit
your research may include (but are not limited to)
the following:
Top of page
What are my additional
responsibilities for clinical research?
Additional institutional requirements that may apply
are described at the following sites:
| • |
UCSF
Guidance |
|
| • |
Cancer research: All human
research on cancer at UCSF must be approved
by the
Cancer
Center before the CHR gives final approval.
Special requirements
of the Cancer Center include submission of a Data
and Safety Monitoring Plan. |
|
| • |
Data
and Safety Monitoring Plans |
|
•
 |
UCSF
Stem Cell Research: There are specific
federal and state restrictions and requirements
on the use of human
stem cells in research. |
Top of page
Top Tips to speed up approval
and prevent problems:
| • |
Use the
application
forms, templates, and standard wording available from the
CHR,
especially the
sample
consent forms. |
|
| • |
Remember that chart reviews,
studies of specimens (even anonymous ones), and
use of information about humans from clinical or
research databases all require CHR review or formal
exemption. |
|
| • |
Do not change your study procedures
or documents without CHR approval. |
|
| • |
Be sure that your protocol
and consent form clearly explain how what happens
to
subjects in the study will be different from what
happens to people
who decline participation. |
|
| • |
All documents and sections of
the application should be consistent; in particular
check the purpose, significance, procedures, benefits,
and alternatives in both the protocol and the consent
form; use the same name for the drugs throughout
the protocol and consent form. |
|
| • |
Use non-technical, everyday
language in the consent form. Avoid all
jargon. |
|
| • |
Do not use acronyms in either
the protocol or the consent form without first
explaining them. |
|
| • |
Keep track of the approval expiration
date and submit your renewal application in time
to receive a new approval before the study expires.
Allow four to six
weeks. |
|
•
 |
Get separate CHR approval for
each discrete study. Do not group
related studies into a complicated application.
You may have several CHR applications for a single
grant. |
Top of page
Relevant policies,
procedures, and ethical statements:
Human subject research is regulated by federal, state,
university, and affiliate regulations, guidance, policies,
and practices. You
are encouraged to follow the guidance found at UCSF’s HSPP web
site, which consolidates the requirements into consistent guidelines.
By following the web site’s guidance, a researcher will automatically
comply with numerous regulations. For reference, major
federal regulations and ethical statements are listed
below. Additional links can be found
at the UCSF Human Subjects Protection Program website.
|